Who
Jens Kemp
Chief Marketing Officer
Company insider
Files Form 4 as: Chief Marketing Officer, Axogen.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $602K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Feb 2024
- Last trade
- 7 May 2026
- Last filed
- 8 May 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 May 2026filed 8 May 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $174K4,000 at $43.44 | filing |
| 7 May 2026filed 8 May 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $174K4,000 at $43.44 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $90K2,952 at $30.65 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $90K2,952 at $30.65 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —50,670 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $492K15,414 at $31.90 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —50,670 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $492K15,414 at $31.90 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $255K8,156 at $31.21 | filing |
| 4 Dec 2025filed 5 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 25 Mar 2025filed 26 Mar 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $73K4,003 at $18.36 | filing |
| 25 Feb 2025filed 5 Mar 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $13K814 at $16.49 | filing |
| 25 Feb 2025filed 26 Feb 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $13K814 at $16.49 | filing |
| 22 Feb 2025filed 5 Mar 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 22 Feb 2025filed 26 Feb 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 22 Feb 2024filed 23 Feb 2024 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —68,600 at $0.00 | filing |
News
Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)AXGN · tickerreport.com · 21 Oct 2026Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Jens Kemp; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.